{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:43:28Z","timestamp":1785437008368,"version":"3.56.0"},"reference-count":43,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Institutes of Health\/National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029795"],"award-info":[{"award-number":["R01EY029795"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R01EY029795"],"award-info":[{"award-number":["R01EY029795"]}],"id":[{"id":"https:\/\/ror.org\/03wkg3b53","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Children\u2019s Research Institute of Wisconsin"},{"name":"Developmental Vascular Biology and Cilia program development funds","award":["R01HL179583"],"award-info":[{"award-number":["R01HL179583"]}]},{"name":"Developmental Vascular Biology and Cilia program development funds","award":["R24OD038116"],"award-info":[{"award-number":["R24OD038116"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Retinopathy of Prematurity (ROP) affects preterm infants worldwide, involving abnormal development of retinal blood vessels associated with supplemental oxygen use in neonatal care. Although there have been strides in identifying at-risk infants, implementing early screening, updating disease criteria through the International Classification of Retinopathy of Prematurity (ICROP), and developing new therapies, ROP remains a leading cause of preventable blindness. As preterm birth survival rates rise, the incidence of ROP continues to increase and is projected to rise even in countries with abundant resources and well-established care programs. Improving ROP care requires global standardization of screening, diagnosis, and management to prevent missed diagnoses and minimize outcome variability. Intravitreal anti-vascular endothelial growth factor (VEGF) injections are changing the landscape of ROP management, but longitudinal research is needed to determine their long-term safety in preterm infants. Effective ROP management relies on teamwork across disciplines and open communication with parents. Given that parents are lifelong caregivers of a child who may be affected by ROP-related vision impairment, including them in the care team and encouraging psychosocial support is vital. Socioeconomic disparities and limited access to ROP-trained ophthalmologists exacerbate disease burden, underscoring the need for innovative solutions to improve access to care. This perspective emphasizes the importance of globally standardizing ROP prevention and care, noting that efforts are still incomplete, equitable access has not been realized, and the long-term role of anti-VEGF agents in ROP treatment remains unclear.<\/jats:p>","DOI":"10.3390\/medicina62050869","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:15:27Z","timestamp":1777630527000},"page":"869","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinopathy of Prematurity (ROP): Are We There Yet?"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2478-8119","authenticated-orcid":false,"given":"Eva","family":"Coughlin","sequence":"first","affiliation":[{"name":"Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waylon","family":"Alvarado","sequence":"additional","affiliation":[{"name":"Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6477-9784","authenticated-orcid":false,"given":"Veluchamy A.","family":"Barathi","sequence":"additional","affiliation":[{"name":"Translational Pre-Clinical Model Platform, Singapore Eye Research Institute, Singapore 169856, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramani","family":"Ramchandran","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Developmental Vascular Biology Program, Department of Pediatrics, Children\u2019s Research Institute (CRI), Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Costakos","sequence":"additional","affiliation":[{"name":"Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Pediatric Ophthalmology, Children\u2019s Wisconsin, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Ramasubramanian","sequence":"additional","affiliation":[{"name":"Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Pediatric Ophthalmology, Children\u2019s Wisconsin, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8725-676X","authenticated-orcid":false,"given":"Shyam S.","family":"Chaurasia","sequence":"additional","affiliation":[{"name":"Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Cell Biology, Neurology and Anatomy Department, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1891\/0730-0832.23.2.31","article-title":"The Discovery of Retrolental Fibroplasia and the Role of Oxygen: A Historical Review, 1942\u20131956","volume":"23","author":"Reedy","year":"2004","journal-title":"Neonatal Netw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/APO.0000000000000313","article-title":"Retinopathy of Prematurity: How to Prevent the Third Epidemic in Developing Countries","volume":"9","author":"Azad","year":"2020","journal-title":"Asia-Pac. J. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3928\/01913913-20210223-01","article-title":"Addressing the Third Epidemic of Retinopathy of Prematurity Through Telemedicine and Technology: A Systematic Review","volume":"58","author":"Valikodath","year":"2021","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e2021053924","DOI":"10.1542\/peds.2021-053924","article-title":"Retinopathy of Prematurity: A Global Perspective and Recent Developments","volume":"150","author":"Sabri","year":"2022","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamaophthalmol.2025.5103","article-title":"Global and Regional Trends in Retinopathy of Prematurity","volume":"144","author":"Wong","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102967","DOI":"10.1016\/j.arcmed.2024.102967","article-title":"Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985\u20132021): A Systematic Review and Meta-Analysis","volume":"55","year":"2024","journal-title":"Arch. Med. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamaophthalmol.2023.0809","article-title":"Epidemiology of Retinopathy of Prematurity in the US From 2003 to 2019","volume":"141","author":"Bhatnagar","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","article-title":"Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study","volume":"136","author":"Quinn","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of Prematurity Treatment: Asian Perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/ojo.OJO_97_2016","article-title":"Risk Factors for Retinopathy of Prematurity in a District in South India: A Prospective Cohort Study","volume":"11","author":"Ahuja","year":"2018","journal-title":"Oman J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102967","DOI":"10.1016\/j.redox.2023.102967","article-title":"Oxidative Stress in the Eye and Its Role in the Pathophysiology of Ocular Diseases","volume":"68","author":"Buonfiglio","year":"2023","journal-title":"Redox Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/sjopt.sjopt_18_22","article-title":"Pathophysiology of Retinopathy of Prematurity","volume":"36","author":"Strube","year":"2022","journal-title":"Saudi J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"(2010). Target Ranges of Oxygen Saturation in Extremely Preterm Infants. N. Engl. J. Med., 362, 1959\u20131969.","DOI":"10.1056\/NEJMoa0911781"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jamaophthalmol.2018.7021","article-title":"Comparison of Biphasic vs Static Oxygen Saturation Targets Among Infants With Retinopathy of Prematurity","volume":"137","author":"Shukla","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.survophthal.2018.04.002","article-title":"Retinopathy of Prematurity: A Review of Risk Factors and Their Clinical Significance","volume":"63","author":"Kim","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening Examination of Premature Infants for Retinopathy of Prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"ref_17","unstructured":"Royal College of Paediatrics and Child Health (2022). UK Screening of Retinopathy of Prematurity Guideline, Royal College of Paediatrics and Child Health. Available online: https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/2024-10\/rop-screening-guideline-full-2022_updated-2024.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.4103\/ijo.IJO_1827_19","article-title":"Operational Guidelines for ROP in India: A Summary","volume":"68","author":"Shukla","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/pch\/15.10.667","article-title":"Retinopathy of Prematurity: Recommendations for Screening","volume":"15","author":"Jefferies","year":"2010","journal-title":"Paediatr. Child Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3928\/23258160-20140122-01","article-title":"Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP): Five Years of Screening With Telemedicine","volume":"45","author":"Fijalkowski","year":"2014","journal-title":"Ophthalmic Surg. Lasers Imaging Retin."},{"key":"ref_21","first-page":"2776","article-title":"The Retinopathy of Prematurity\u2014Save Our Sight Program: Analysis of Gender and Socioeconomic Status in a ROP Telemedicine Program in Southern India","volume":"59","author":"Beca","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International Classification of Retinopathy of Prematurity, Third Edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/0301-4738.71689","article-title":"Technical Aspects of Laser Treatment for Acute Retinopathy of Prematurity under Topical Anesthesia","volume":"58","author":"Jalali","year":"2010","journal-title":"Indian J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s40123-023-00744-7","article-title":"Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity","volume":"12","author":"Hartnett","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity","volume":"364","author":"Kennedy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jamaophthalmol.2017.1055","article-title":"Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity","volume":"135","author":"Wallace","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus Laser Therapy for the Treatment of Very Low Birthweight Infants with Retinopathy of Prematurity (RAINBOW): An Open-Label Randomised Controlled Trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1001\/jama.2022.10564","article-title":"Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial","volume":"328","author":"Stahl","year":"2022","journal-title":"J. Am. Med. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2352-4642(21)00195-4","article-title":"2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): Prospective follow-up of an open-label, randomised controlled trial","volume":"5","author":"Marlow","year":"2021","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_30","first-page":"e73286","article-title":"Recurrence of Retinopathy of Prematurity Following Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Therapy: A Systematic Review and Meta-Analysis","volume":"16","author":"Dablouk","year":"2024","journal-title":"Cureus"},{"key":"ref_31","unstructured":"(2026, April 14). Retinopathy of Prematurity\u2014American Association for Pediatric Ophthalmology and Strabismus. Available online: https:\/\/aapos.org\/glossary\/retinopathy-of-prematurity."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41372-024-01997-1","article-title":"Aflibercept to Treat Retinopathy of Prematurity: Need for More Research","volume":"45","author":"Raghuveer","year":"2025","journal-title":"J. Perinatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"(2006). The Early Treatment for Retinopathy of Prematurity Cooperative Group. The Early Treatment for Retinopathy Of Prematurity Study: Structural Findings at Age 2 Years. Br. J. Ophthalmol., 90, 1378\u20131382.","DOI":"10.1136\/bjo.2006.098582"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clp.2013.02.006","article-title":"Setting Up and Improving Retinopathy of Prematurity Programs: Interaction of Neonatology, Nursing, and Ophthalmology","volume":"40","author":"Darlow","year":"2013","journal-title":"Clin. Perinatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4103\/ijo.IJO_2707_20","article-title":"Should Parents Be Present during Screening Examinations for Retinopathy of Prematurity?","volume":"69","author":"Kara","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4103\/ijo.IJO_763_21","article-title":"Commentary: Parental Involvement in Retinopathy of Prematurity Care: An Individualized Approach","volume":"69","author":"Sindal","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2018.03.039","article-title":"Parents\u2019 Knowledge and Education of Retinopathy of Prematurity in Four California Neonatal Intensive Care Units","volume":"191","author":"Liu","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4103\/ijo.IJO_323_19","article-title":"Vision-Related Quality of Life in Children with Treated Retinopathy of Prematurity","volume":"67","author":"Kesarwani","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ophtha.2023.04.004","article-title":"Causes of Childhood Blindness in the United States Using the IRIS\u00ae Registry (Intelligent Research in Sight)","volume":"130","author":"Lim","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.oret.2023.10.003","article-title":"The Incidence and Timing of Treatment-Requiring Retinopathy of Prematurity in Nanopremature and Micropremature Infants in the United States: A National Multicenter Retrospective Cohort Study","volume":"8","author":"Scarboro","year":"2024","journal-title":"Ophthalmol. Retin."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"100094","DOI":"10.1016\/j.xops.2021.100094","article-title":"Peripheral OCT Assisted by Scleral Depression in Retinopathy of Prematurity","volume":"2","author":"Scruggs","year":"2021","journal-title":"Ophthalmol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.9.2.10","article-title":"Plus Disease in Retinopathy of Prematurity: Convolutional Neural Network Performance Using a Combined Neural Network and Feature Extraction Approach","volume":"9","author":"Yildiz","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/bjo-2025-327597","article-title":"Reactivation of Retinopathy of Prematurity after Anti-VEGF Treatment: A Review","volume":"110","author":"Kumawat","year":"2026","journal-title":"Br. J. Ophthalmol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/869\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:35:28Z","timestamp":1777631728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050869"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050869","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}